financetom
Business
financetom
/
Business
/
Inseego Q3 revenue beats estimates on strong fixed wireless access demand 
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Inseego Q3 revenue beats estimates on strong fixed wireless access demand 
Nov 6, 2025 1:40 PM

Overview

* Inseego Q3 2025 revenue of $45.9 mln beats analyst expectations

* Adjusted EBITDA for Q3 2025 beats consensus, reflecting quality growth

* Net income for Q3 2025 missed analyst estimates

Outlook

* Inseego forecasts Q4 2025 revenue between $45.0 mln and $48.0 mln

* Company expects Q4 2025 adjusted EBITDA between $4.0 mln and $5.0 mln

* Q4 guidance excludes potential tariff impacts

Result Drivers

* STRONG FWA DEMAND - Inseego ( INSG ) attributes sequential revenue growth to strong demand for its FX4100 and FX4200 FWA solutions

* EXPANDED CUSTOMER BASE - Co secured a new Tier-1 U.S. carrier customer for its next-generation products, boosting future shipments

* DISCIPLINED EXPENSE MANAGEMENT - CFO highlights disciplined expense management contributing to operating leverage

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $45.89 $41.86

Revenue mln mln (4

Analysts

)

Q3 Net Miss $1.43 $1.63

Income mln mln (3

Analysts

)

Q3 Beat $5.80 $4.61

Adjusted mln mln (4

EBITDA Analysts

)

Q3 Miss $2.16 $3.05

Operatin mln mln (4

g Income Analysts

)

Q3 Beat $1.40 $1.26

Pretax mln mln (4

Profit Analysts

)

Q3 Gross $19.08

Profit mln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the communications & networking peer group is "buy"

* Wall Street's median 12-month price target for Inseego Corp ( INSG ) is $13.75, about 4.7% below its November 5 closing price of $14.40

* The stock recently traded at 27 times the next 12-month earnings vs. a P/E of 13 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Casey's General Stores Fiscal Q2 Earnings Increase, Revenue Declines
Casey's General Stores Fiscal Q2 Earnings Increase, Revenue Declines
Dec 9, 2024
05:04 PM EST, 12/09/2024 (MT Newswires) -- Casey's General Stores (CASY) reported fiscal Q2 earnings late Monday of $4.85 per diluted share, up from $4.24 a year earlier. Four analysts polled by FactSet expected $4.25. Revenue for the quarter ended Oct. 31 was $3.95 billion, down from $4.06 billion a year earlier. Analysts surveyed by FactSet expected $4.03 billion. Shares...
Edwards Lifesciences Insider Sold Shares Worth $358,751, According to a Recent SEC Filing
Edwards Lifesciences Insider Sold Shares Worth $358,751, According to a Recent SEC Filing
Dec 9, 2024
05:02 PM EST, 12/09/2024 (MT Newswires) -- Donald E Bobo Jr, Corporate Vice President, Strategy and Business Development, on December 09, 2024, sold 5,000 shares in Edwards Lifesciences ( EW ) for $358,751. Following the Form 4 filing with the SEC, Bobo has control over a total of 220,704 shares of the company, with 46,936 shares held directly and 173,769...
Celanese Names Scott Richardson CEO
Celanese Names Scott Richardson CEO
Dec 9, 2024
05:06 PM EST, 12/09/2024 (MT Newswires) -- Celanese (CE) said Monday it appointed its Chief Operating Officer, Scott Richardson, as Chief Executive, starting Jan. 1, 2025. Richardson will succeed Lori Ryerkerk, who is stepping down as chairman, CEO, and director of the company at year-end. Celanese appointed Edward Galante as chair of the board, effective upon Ryerkerk's departure, the company...
Edwards Lifesciences Insider Sold Shares Worth $806,406, According to a Recent SEC Filing
Edwards Lifesciences Insider Sold Shares Worth $806,406, According to a Recent SEC Filing
Dec 9, 2024
05:02 PM EST, 12/09/2024 (MT Newswires) -- Scott B. Ullem, Corporate Vice President, Chief Financial Officer, on December 09, 2024, sold 11,250 shares in Edwards Lifesciences ( EW ) for $806,406. Following the Form 4 filing with the SEC, Ullem has control over a total of 296,879 shares of the company, with 30,561 shares held directly and 266,318 controlled indirectly....
Copyright 2023-2026 - www.financetom.com All Rights Reserved